Novavax Inc. (NVAX)
NASDAQ · Healthcare
Novavax Inc. Operating Income 2010–2025
Novavax Inc. annual/quarterly operating income history and growth rate from 2010 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Novavax Inc. operating income for the quarter ending March 31, 2026 was -15.4 M, a 102.99% decrease year-over-year.
- Novavax Inc. operating income for the twelve months ending March 31, 2026 was 423.1 M, a 273.78% decrease year-over-year.
- Novavax Inc. annual operating income for 2025 was 452.8 M, a 281.90% decrease from 2024.
- Novavax Inc. annual operating income for 2024 was -248.9 M, a 56.06% decrease from 2023.
- Novavax Inc. annual operating income for 2023 was -566.5 M, a 12.13% decrease from 2022.
- Novavax Inc. annual operating income for 2022 was -644.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Novavax Inc. Operating Income — FAQ
Novavax Inc. (NVAX) operating income over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is Novavax Inc.'s operating income?
Novavax Inc. (NVAX) reported operating income of $453M for fiscal 2025.
Where can I see NVAX's operating income history?
The chart and table above show Novavax Inc.'s operating income by year and by quarter, including the growth rate.